{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:26:00Z","timestamp":1792671960929,"version":"4.5.0"},"reference-count":75,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2016,3,31]]},"DOI":"10.3233\/jhd-150181","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T17:15:45Z","timestamp":1459444545000},"page":"65-81","source":"Crossref","is-referenced-by-count":29,"title":["Partial Amelioration of Peripheral and Central Symptoms of Huntington\u2019s Disease via Modulation of Lipid Metabolism"],"prefix":"10.1177","volume":"5","author":[{"given":"Jane Y.","family":"Chen","sequence":"first","affiliation":[{"name":"Intellectual and Developmental Disabilities Research Center, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conny","family":"Tran","sequence":"additional","affiliation":[{"name":"Intellectual and Developmental Disabilities Research Center, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Hwang","sequence":"additional","affiliation":[{"name":"Pasarow Mass Spectrometry Laboratory, David Geffen School of Medicine, University of California Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, David Geffen School of Medicine, University of California Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, David Geffen School of Medicine, University of California Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kym F.","family":"Faull","sequence":"additional","affiliation":[{"name":"Pasarow Mass Spectrometry Laboratory, David Geffen School of Medicine, University of California Los Angeles, CA, USA"},{"name":"Brain Research Institute, David Geffen School of Medicine, University of California Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Levine","sequence":"additional","affiliation":[{"name":"Intellectual and Developmental Disabilities Research Center, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California Los Angeles, CA, USA"},{"name":"Brain Research Institute, David Geffen School of Medicine, University of California Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Cepeda","sequence":"additional","affiliation":[{"name":"Intellectual and Developmental Disabilities Research Center, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JHD-150181_ref1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JHD-150181_ref2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1212\/01.wnl.0000174432.87383.87","article-title":"Regional cortical thinning in preclinical Huntington disease and its relationship to cognition","volume":"65","author":"Rosas","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JHD-150181_ref3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/hmg\/ddi004","article-title":"Orexin loss in Huntington\u2019s disease","volume":"14","author":"Petersen","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-150181_ref4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s004010050408","article-title":"Nerve cell loss in the thalamic centromedian-parafascicular complex in patients with Huntington\u2019s disease","volume":"91","author":"Heinsen","year":"1996","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JHD-150181_ref5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1212\/WNL.0b013e3181b04aa2","article-title":"Dietary intake in adults at risk for Huntington disease: Analysis of PHAROS research participants","volume":"73","author":"Marder","year":"2009","journal-title":"Neurology"},{"key":"10.3233\/JHD-150181_ref6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/archneur.65.4.476","article-title":"Glucose homeostasis in Huntington disease: Abnormalities in insulin sensitivity and early-phase insulin secretion","volume":"65","author":"Lalic","year":"2008","journal-title":"Arch Neurol"},{"key":"10.3233\/JHD-150181_ref7","first-page":"19","article-title":"Insulin and insulin resistance","volume":"26","author":"Wilcox","year":"2005","journal-title":"Clin Biochem Rev"},{"key":"10.3233\/JHD-150181_ref8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/hmg\/ddi053","article-title":"The R6\/2 transgenic mouse model of Huntington\u2019s disease develops diabetes due to deficient beta- cell mass and exocytosis","volume":"14","author":"Bjorkqvist","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-150181_ref9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2337\/diabetes.48.3.649","article-title":"Mice transgenic for an expanded CAG repeat in the Huntington\u2019s disease gene develop diabetes","volume":"48","author":"Hurlbert","year":"1999","journal-title":"Diabetes"},{"key":"10.3233\/JHD-150181_ref10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/hmg\/10.2.145","article-title":"Abnormalities in the functioning of adipocytes from R6\/2 mice that are transgenic for the Huntington\u2019s disease mutation","volume":"10","author":"Fain","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-150181_ref11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cmet.2011.02.013","article-title":"Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits","volume":"13","author":"Hult","year":"2011","journal-title":"Cell Metab"},{"key":"10.3233\/JHD-150181_ref12","first-page":"149","article-title":"Ketoacids? Good medicine?","volume":"114","author":"Cahill","year":"2003","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"10.3233\/JHD-150181_ref13","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.ebiom.2015.11.002","article-title":"White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer\u2019s Disease","volume":"2","author":"Klosinski","year":"2015","journal-title":"EBioMedicine"},{"key":"10.3233\/JHD-150181_ref14","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.tins.2011.06.005","article-title":"Emerging roles for cholesterol in Huntington\u2019s disease","volume":"34","author":"Valenza","year":"2011","journal-title":"Trends Neurosci"},{"key":"10.3233\/JHD-150181_ref15","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","article-title":"Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal","volume":"45","author":"Dietschy","year":"2004","journal-title":"J Lipid Res"},{"key":"10.3233\/JHD-150181_ref16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1113\/jphysiol.2006.123133","article-title":"Cholesterol-dependent balance between evoked and spontaneous synaptic vesicle recycling","volume":"579","author":"Wasser","year":"2007","journal-title":"J Physiol"},{"key":"10.3233\/JHD-150181_ref17","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1523\/JNEUROSCI.23-08-03262.2003","article-title":"Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability","volume":"23","author":"Hering","year":"2003","journal-title":"J Neurosci"},{"key":"10.3233\/JHD-150181_ref18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jnr.22184","article-title":"Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington\u2019s disease","volume":"88","author":"Valencia","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.3233\/JHD-150181_ref19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nm0309-253","article-title":"Getting a handle on Huntington\u2019s disease: The case for cholesterol","volume":"15","author":"Katsuno","year":"2009","journal-title":"Nat Med"},{"key":"10.3233\/JHD-150181_ref20","doi-asserted-by":"crossref","first-page":"292598","DOI":"10.1155\/2012\/292598","article-title":"Cholesterol: Its regulation and role in central nervous system disorders","volume":"2012","author":"Orth","year":"2012","journal-title":"Cholesterol"},{"key":"10.3233\/JHD-150181_ref21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nbd.2007.07.004","article-title":"Progressive dysfunction of the cholesterol biosynthesis pathway in the R6\/2 mouse model of Huntington\u2019s disease","volume":"28","author":"Valenza","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JHD-150181_ref22","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","article-title":"Dysfunction of the cholesterol biosynthetic pathway in Huntington\u2019s disease","volume":"25","author":"Valenza","year":"2005","journal-title":"J Neurosci"},{"key":"10.3233\/JHD-150181_ref23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pneurobio.2006.11.001","article-title":"The corticostriatal pathway in Huntington\u2019s disease","volume":"81","author":"Cepeda","year":"2007","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JHD-150181_ref24","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1523\/JNEUROSCI.23-03-00961.2003","article-title":"Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington\u2019s disease","volume":"23","author":"Cepeda","year":"2003","journal-title":"J Neurosci"},{"key":"10.3233\/JHD-150181_ref25","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1152\/jn.2001.86.6.2667","article-title":"Electrophysiological and morphological changes in striatal spiny neurons in R6\/2 Huntington\u2019s disease transgenic mice","volume":"86","author":"Klapstein","year":"2001","journal-title":"J Neurophysiol"},{"key":"10.3233\/JHD-150181_ref26","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/hmg\/ddl224","article-title":"Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington\u2019s disease","volume":"15","author":"Cummings","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-150181_ref27","doi-asserted-by":"crossref","first-page":"e00036","DOI":"10.1042\/AN20100007","article-title":"Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington\u2019s disease","volume":"2","author":"Cummings","year":"2010","journal-title":"ASN Neuro"},{"key":"10.3233\/JHD-150181_ref28","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1523\/JNEUROSCI.3539-10.2011","article-title":"Differential electrophysiological changes in striatal output neurons in Huntington\u2019s disease","volume":"31","author":"Andre","year":"2011","journal-title":"J Neurosci"},{"key":"10.3233\/JHD-150181_ref29","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/jnr.20344","article-title":"Increased GABAergic function in mouse models of Huntington\u2019s disease: Reversal by BDNF","volume":"78","author":"Cepeda","year":"2004","journal-title":"J Neurosci Res"},{"key":"10.3233\/JHD-150181_ref30","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.brainresrev.2008.12.001","article-title":"The R6 lines of transgenic mice: A model for screening new therapies for Huntington\u2019s disease","volume":"59","author":"Gil","year":"2009","journal-title":"Brain Res Rev"},{"key":"10.3233\/JHD-150181_ref31","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3233\/JHD-150170","article-title":"Brain Cholesterol Synthesis and Metabolism is Progressively Disturbed in the R6\/1 Mouse Model of Huntington\u2019s Disease: A Targeted GC-MS\/MS Sterol Analysis","volume":"4","author":"Kreilaus","year":"2015","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-150181_ref32","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1471-4159.2009.06506.x","article-title":"Energy substrate availability as a determinant of neuronal resting potential, GABA signaling and spontaneous network activity in the neonatal cortex in vitro","volume":"112","author":"Holmgren","year":"2010","journal-title":"J Neurochem"},{"key":"10.3233\/JHD-150181_ref33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1677\/JOE-09-0271","article-title":"Liver X receptor in cholesterol metabolism","volume":"204","author":"Zhao","year":"2010","journal-title":"J Endocrinol"},{"key":"10.3233\/JHD-150181_ref34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.eplepsyres.2011.05.021","article-title":"The ketogenic diet: What has science taught us?","volume":"100","author":"Rho","year":"2012","journal-title":"Epilepsy Res"},{"key":"10.3233\/JHD-150181_ref35","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/epi.13075","article-title":"Dietary therapy is the best option for refractory nonsurgical epilepsy","volume":"56","author":"Felton","year":"2015","journal-title":"Epilepsia"},{"key":"10.3233\/JHD-150181_ref36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fphar.2012.00059","article-title":"The ketogenic diet as a treatment paradigm for diverse neurological disorders","volume":"3","author":"Stafstrom","year":"2012","journal-title":"Front Pharmacol"},{"key":"10.3233\/JHD-150181_ref37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.plefa.2003.07.006","article-title":"Brain uptake and metabolism of ketone bodies in animal models","volume":"70","author":"Nehlig","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.3233\/JHD-150181_ref38","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1523\/JNEUROSCI.2137-12.2013","article-title":"Multiple sources of striatal inhibition are differentially affected in Huntington\u2019s disease mouse models","volume":"33","author":"Cepeda","year":"2013","journal-title":"J Neurosci"},{"key":"10.3233\/JHD-150181_ref39","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/jmg.2009.066399","article-title":"Wild- type but not mutant huntingtin modulates the transcriptional activity of liver X receptors","volume":"46","author":"Futter","year":"2009","journal-title":"J Med Genet"},{"key":"10.3233\/JHD-150181_ref40","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.physbeh.2011.04.001","article-title":"A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6\/2 1J mouse model of Huntington\u2019s disease","volume":"103","author":"Ruskin","year":"2011","journal-title":"Physiol Behav"},{"key":"10.3233\/JHD-150181_ref41","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.bbalip.2014.12.018","article-title":"The impairment of cholesterol metabolism in Huntington disease","volume":"1851","author":"Leoni","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JHD-150181_ref42","doi-asserted-by":"crossref","first-page":"e0146480","DOI":"10.1371\/journal.pone.0146480","article-title":"A Metabolic Study of Huntington\u2019s Disease","volume":"11","author":"Nambron","year":"2016","journal-title":"PLoS One"},{"key":"10.3233\/JHD-150181_ref43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pneurobio.2006.09.005","article-title":"Cholesterol dysfunction in neurodegenerative diseases: Is huntington\u2019s disease in the list?","volume":"80","author":"Valenza","year":"2006","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JHD-150181_ref44","doi-asserted-by":"crossref","first-page":"10844","DOI":"10.1523\/JNEUROSCI.0917-10.2010","article-title":"Cholesterol defect is marked across multiple rodent models of Huntington\u2019s disease and is manifest in astrocytes","volume":"30","author":"Valenza","year":"2010","journal-title":"J Neurosci"},{"key":"10.3233\/JHD-150181_ref45","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/cdd.2014.162","article-title":"Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington\u2019s disease","volume":"22","author":"Valenza","year":"2015","journal-title":"Cell Death Differ"},{"key":"10.3233\/JHD-150181_ref46","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1093\/hmg\/ddl434","article-title":"Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo","volume":"15","author":"Trushina","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-150181_ref47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1471-4159.2010.06912.x","article-title":"Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington\u2019s disease","volume":"115","author":"del Toro","year":"2010","journal-title":"J Neurochem"},{"key":"10.3233\/JHD-150181_ref48","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1073\/pnas.1002924107","article-title":"SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis","volume":"107","author":"Luthi-Carter","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JHD-150181_ref49","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1021\/cb100376q","article-title":"A brain- permeable small molecule reduces neuronal cholesterol by inhibiting activity of sirtuin 2 deacetylase","volume":"6","author":"Taylor","year":"2011","journal-title":"ACS Chem Biol"},{"key":"10.3233\/JHD-150181_ref50","doi-asserted-by":"crossref","first-page":"E143","DOI":"10.1073\/pnas.1006783107","article-title":"Neuroprotection and brain cholesterol biosynthesis in Huntington\u2019s disease","volume":"107","author":"Valenza","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JHD-150181_ref51","first-page":"e505886e9a1968","article-title":"Pitfalls in the detection of cholesterol in Huntington\u2019s disease models","volume":"4","author":"Marullo","year":"2012","journal-title":"PLoS Curr"},{"key":"10.3233\/JHD-150181_ref52","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrneurol.2011.132","article-title":"Cholesterol metabolism in Huntington disease","volume":"7","author":"Karasinska","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JHD-150181_ref53","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awv384","article-title":"CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington\u2019s disease","volume":"139","author":"Boussicault","year":"2016","journal-title":"Brain"},{"key":"10.3233\/JHD-150181_ref54","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/j.1471-4159.2009.06230.x","article-title":"GABA action in immature neocortical neurons directly depends on the availability of ketone bodies","volume":"110","author":"Rheims","year":"2009","journal-title":"J Neurochem"},{"key":"10.3233\/JHD-150181_ref55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fnene.2011.00009","article-title":"Critical state of energy metabolism in brain slices: The principal role of oxygen delivery and energy substrates in shaping neuronal activity","volume":"3","author":"Ivanov","year":"2011","journal-title":"Front Neuroenergetics"},{"key":"10.3233\/JHD-150181_ref56","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/JAD-2010-101653","article-title":"Simvastatin is the statin that most efficiently protects against kainate-induced excitotoxicity and memory impairment","volume":"24","author":"Ramirez","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JHD-150181_ref57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fnins.2015.00017","article-title":"A unique array of neuroprotective effects of pyruvate in neuropathology","volume":"9","author":"Zilberter","year":"2015","journal-title":"Front Neurosci"},{"key":"10.3233\/JHD-150181_ref58","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat Med"},{"key":"10.3233\/JHD-150181_ref59","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/156720507780362173","article-title":"Liver X receptor-mediated gene regulationand cholesterol homeostasis in brain: Relevance to Alzheimer\u2019s disease therapeutics","volume":"4","author":"Cao","year":"2007","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JHD-150181_ref60","doi-asserted-by":"crossref","first-page":"10601","DOI":"10.1073\/pnas.0701096104","article-title":"Attenuation of neuroinflammation and Alzheimer\u2019s disease pathology by liver x receptors","volume":"104","author":"Zelcer","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JHD-150181_ref61","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1385\/NMM:8:3:319","article-title":"Cholesterol distribution, not total levels, correlate with altered amyloid precursor protein processing in statin-treated mice","volume":"8","author":"Burns","year":"2006","journal-title":"Neuromolecular Med"},{"key":"10.3233\/JHD-150181_ref62","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00008877-200609000-00009","article-title":"Neuroprotective and disease-modifying effects of the ketogenic diet","volume":"17","author":"Gasior","year":"2006","journal-title":"Behav Pharmacol"},{"issue":"Suppl 8","key":"10.3233\/JHD-150181_ref63","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1528-1167.2008.01846.x","article-title":"Energy metabolism as part of the anticonvulsant mechanism of the ketogenic diet","volume":"49","author":"Bough","year":"2008","journal-title":"Epilepsia"},{"key":"10.3233\/JHD-150181_ref64","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(88)90814-X","article-title":"Kynurenate and FG9041 have both competitive and non-competitive antagonist actions at excitatory amino acid receptors","volume":"151","author":"Birch","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.3233\/JHD-150181_ref65","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0022-3565(25)38782-3","article-title":"Kynurenic acid and quinolinic acid act at N-methyl-D- aspartate receptors in the rat hippocampus","volume":"236","author":"Ganong","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3233\/JHD-150181_ref66","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00702-011-0750-2","article-title":"Ketogenic diet increases concentrations of kynurenic acid in discrete brain structures of young and adult rats","volume":"119","author":"Zarnowski","year":"2012","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JHD-150181_ref67","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nbd.2004.07.006","article-title":"Neostriatal and cortical quinolinate levels are increased in early grade Huntington\u2019s disease","volume":"17","author":"Guidetti","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JHD-150181_ref68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0306-4522(01)00409-2","article-title":"Essential fatty acids given from conception prevent topographies of motor deficit in a transgenic model of Huntington\u2019s disease","volume":"109","author":"Clifford","year":"2002","journal-title":"Neuroscience"},{"key":"10.3233\/JHD-150181_ref69","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","article-title":"Plasma inflammatory biomarkers for Huntington\u2019s disease patients and mouse model","volume":"44","author":"Chang","year":"2015","journal-title":"Brain Behav Immun"},{"key":"10.3233\/JHD-150181_ref70","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/mp.2011.28","article-title":"The role of immunity in Huntington\u2019s disease","volume":"16","author":"Soulet","year":"2011","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JHD-150181_ref71","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JHD-150181_ref72","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/0896-6273(93)90127-D","article-title":"Huntington\u2019s disease gene (IT15) is widely expressed in human and rat tissues","volume":"11","author":"Li","year":"1993","journal-title":"Neuron"},{"key":"10.3233\/JHD-150181_ref73","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1093\/hmg\/ddi192","article-title":"Gene expression in Huntington\u2019s disease skeletal muscle: A potential biomarker","volume":"14","author":"Strand","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-150181_ref74","first-page":"237","article-title":"Therapeutic perspectives for the treatment of Huntington\u2019s disease: Treating the whole body","volume":"23","author":"Martin","year":"2008","journal-title":"Histol-Histopathol"},{"key":"10.3233\/JHD-150181_ref75","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.15252\/emmm.201505413","article-title":"Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington\u2019s disease mice","volume":"7","author":"Valenza","year":"2015","journal-title":"EMBO Mol Med"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-150181","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:57:07Z","timestamp":1777453027000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-150181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,31]]},"references-count":75,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jhd-150181","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,31]]}}}